0001209191-18-052558.txt : 20180928 0001209191-18-052558.hdr.sgml : 20180928 20180928162302 ACCESSION NUMBER: 0001209191-18-052558 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20180926 FILED AS OF DATE: 20180928 DATE AS OF CHANGE: 20180928 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: EDWARDS JEFFREY L CENTRAL INDEX KEY: 0001190642 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-37783 FILM NUMBER: 181094441 MAIL ADDRESS: STREET 1: 2525 DUPONT DR CITY: IRVINE STATE: CA ZIP: 92612 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Clearside Biomedical, Inc. CENTRAL INDEX KEY: 0001539029 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 452437375 STATE OF INCORPORATION: GA FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 900 NORTH POINT PARKWAY STREET 2: SUITE 200 CITY: ALPHARETTA STATE: 2Q ZIP: 30005 BUSINESS PHONE: 678-270-3631 MAIL ADDRESS: STREET 1: 900 NORTH POINT PARKWAY STREET 2: SUITE 200 CITY: ALPHARETTA STATE: 2Q ZIP: 30005 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2018-09-26 0 0001539029 Clearside Biomedical, Inc. CLSD 0001190642 EDWARDS JEFFREY L C/O CLEARSIDE BIOMEDICAL, INC. 900 NORTH POINT PARKWAY, SUITE 200 ALPHARETTA GA 30005 1 0 0 0 Stock Option (right to buy) 6.03 2018-09-26 4 A 0 22500 0.00 A 2028-09-25 Common Stock 22500 22500 D This option will vest and become exercisable in 36 equal monthly installments through September 26, 2021, subject to the reporting person's continuous service as of such vesting dates. /s/ Mark Ballantyne, Attorney-in-Fact 2018-09-28